Pathogenesis and prevention of adhesion formation

Digestive Surgery

Volumn 15, Issue 2, 1998, Pages 153-157

  Thompson, Jeremy ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Adhesion; Mesothelium; Peritoneum; Plasminogen activator; Plasminogen activator inhibitors

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; CARBOXYMETHYLCELLULOSE; CISAPRIDE; CORTICOSTEROID; DEXTRAN 70; NONSTEROID ANTIINFLAMMATORY AGENT; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR; POVIDONE IODINE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADHESION; APPENDECTOMY; APPENDICITIS; ARTICLE; FIBRINOLYSIS; HUMAN; INFLAMMATION; LAPAROSCOPIC SURGERY; MEMBRANE; PATHOGENESIS; PERITONEUM; POSTOPERATIVE COMPLICATION;

ADHESIONS; FIBRINOLYSIS; HUMANS; PERITONEUM; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 0031920120     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018610     Document Type: Article

References (34)

1. Thompson JN, Whawell SA: The pathogenesis and prevention of adhesion formation. Br J Surg 1995;82:3-5.
2. Menzies D, Ellis H: Intestinal obstruction from adhesions: How big is the probelm? Ann R Coll Surg Engl 1990;72:60-63.
3. Bevan PG: Adhesive obstruction. Ann R Coll Surg Engl 1984;66:164-169.
4. Raf LE: Causes of abdominal adhesions in cases of intestinal obstruction. Acta Chir Scand 1969;135:73-76.
5. McEntee G, Pender D, Mulvin D, et al: Current spectrum of intestinal obstruction. Br J Surg 1987;74:976-980.
6. Tanphiphat C, Chittmittrapap S, Prasopsunti K: Adhesive small bowel obstruction: A review of 321 cases in a Thai hospital. Am J Surg 1987; 154:283-287.
7. Füzun M, Kaymak E, Harmancioglu O, Astarcioglu K: Principal causes of mechanical bowel obstruction in surgically treated adults in western Turkey. Br J Surg 1991;78:202-203.
8. Scott-Coombes DM, Vipond MN, Thompson JN: Surgeons attitudes to the treatment and prevention of abdominal adhesions. Ann R Coll Surg Engl 1993;75:123-128.
9. Ray NF, Larsen JW, Stillman RJ, Jacobs J: Economic impact of hospitalizations for lower abdominal adhesiolysis in the United States in 1988. Surg Gynecol Obstet 1993;176:271-276.
10. Johnson FR, Whiting HW: Repair of parietal peritoneum. Br J Surg 1962;49:653-660.
11. Raftery AT: Regeneration of parietal and visceral peritoneum: An electron microscopical study. J Anat 1973;115:375-392.
12. Myrhe-Jensen O, Larsen SB, Astrup T: Fibrinolytic activity in serosal and synovial membranes. Arch Pathol 1969;88:623-630.
13. Porter JM, Ball AP, Silver D: Mesothelial fibrinolysis. J Thorac Cardiol Vase Surg 1971;62: 725-730.
14. Buckman RF, Buckman D, Hufnagel HB, Gervin AS: A physiological basis for the adhesion-free healing of the peritonealised surfaces. J Surg Res 1976;21:67-76.
15. Thompson JN, Patterson-Brown S, Harbourne T, Whawell SA, Kalodiki E, Dudley HAF: Reduced human peritoneal plasminogen activating activity: As possible mechanism of adhesion formation. Br J Surg 1989;76:382-384.
16. Vipond MN, Whawell SA, Thompson JN, Dudley HAF: Peritoneal fibrinolytic activity and intra-abdominal adhesions. Lancet 1990;i: 1120-1122.
17. Holmdahl L, Eriksson E, Al-Jabreen M, Risberg B: Fibrinolysis in Human Peritoneum during Surgery; thesis, University of Goteborg, 1994.
18. Scott-Coombes DM, Whawell SA, Vipond MN, Thompson JN: The human intraperitoneal fibrinolytic response to elective surgery. Br J Surg 1995;82:414-417.
19. Whawell SA, Vipond MN, Scott-Coombes DM, Thompson JN: Plasminogen activator inhibitor-2 inhibits peritoneal fibrinolytic activity in inflammation. Br J Surg 1993;80:107-109.
20. Whawell SA, Wang Y, Fleming KA, Thompson EM, Thompson JN: Localisation of plasminogen activator inhibitor-1 production in inflamed appendix by in situ mRNA hybridisation. J Pathol 1993;169:67-71.
21. Whawell SA, Thompson EM, Fleming KA, Thompson JN: Plasminogen activator inhibitor-2 expression in inflamed appendix. Histophathology 1995;27:75-78.
22. Vipond MN, Whawell SA, Thompson JN, Dudley HAF: Effect of experimental peritonitis and ischaemia on peritoneal fibrinolytic activity. Eur J Surg 1994;160:471-477.
23. Badia JM, Scott-Coombes DM, Whawell SA, Abel PD, Williamson RCN: Peritoneal and systemic cytokine response to laparotomy. Br J Surg 1996;83:347-348.
24. Van Hinsbergh VWM, Kooistra T, Schaffer MA, Van Bockel JM, Van Muijen GMP: Characterisation and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990;75: 1490-1497.
25. Whawell SA, Scott-Coombes DM, Vipond MN, Tebbutt SJ, Thompson JN: Tumour necrosis factor mediated release of plasminogen acitvator inhibitor-1 by human peritoneal mesothelial cells. Br J Surg 1994;81:214-216.
26. Watson RW, Redmond HP, McCarthy J, Burke PE, Bouchier-Hayes D: Exposure of the peritoneal cavity to air regulates early inflammatory responses to surgery in a murine model. Br J Surg 1995;82:1060-1065.
27. diZerega GS: Contemporary adhesion prevention. Fertil Steril 1994;61:219-235.
28. Wiseman D: Polymers for the prevention of surgical adhesions; in Domb AJ (ed): Polymeric Site-Specific Pharmacotherapy. Chichester, Wiley, 1994, pp 369-421.
29. Menzies D, Ellis H: The role of plasminogen activation in adhesion prevention. Surg Gynecol Obstet 1991;172:362-366.
30. Vipond MN, Whawell SA, Scott-Coombes DM, Thompson JN, Dudley HAF: Experimental adhesion prophylaxis with recombinant tissue plasminogen activator. Ann R Coll Surg Engl 1994;76:412-415.
31. Interceed (TC7) Adhesion Barrier Study Group: Prevention of postsurgical adhesions by Interceed (TC7), an absorbable adhesion barrier: A prospective, randomized multicenter clinical study. Fertil Steril 1989;51:933-938.
32. Sekiba K, Obstetrics and Gynecology Adhesion Prevention Committee: Use of Interceed (TC7) absorbable adhesion barrier to reduce postop-erative adhesion reformation in infertility and endometriosis surgery. Obstet Gynecol 1992; 79:518-522.
33. Becker JM, Dayton MT, Fazio VW, et al: Sodium hyaluronate-based bioresorbable membrane (HAL-F) in the prevention of postoperative abdominal adhesions: A prospective, randomized, double-blinded multicenter study. Am Coll Surg Meet, 1995.
34. Diamond M: Seprafilm™ (HAL-F™) reduces postoperative adhesions: Initial results of a multicenter gynecologic clinical study. 4th Congr Eur Soc Gynaecol Endosc, 1995.